Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Graham

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Biology Letters|January 18, 2023
Directional hydrophone clusters reveal evasive responses of small cetaceans to disturbance during construction at offshore windfarmsI M Graham, D Gillespie, K C Gkikopoulou, et al.
Circulation|May 31, 2001
Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action ProjectL El-Khairy, P M Ueland, H Refsum, et al.
Scandinavian Journal of Social Medicine|January 1, 1986
The relation of social class to risk factors, rehabilitation, compliance and mortality in survivors of acute coronary heart diseaseR M Conroy, S Cahill, R Mulcahy, et al.
Clinical and Experimental Dermatology|June 16, 2010
Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control studyA-M Tobin, R Hughes, E B Hand, et al.
European Heart Journal|August 24, 1999
Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC GroupP Verhoef, R Meleady, L E Daly, et al.
Advances in Therapy|August 4, 2009
Dyslipidemia therapy update: the importance of full lipid profile assessmentI B A Menown, G Murtagh, V Maher, et al.
Circulation|August 10, 2000
Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromesP J Stubbs, M K Al-Obaidi, R M Conroy, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 10, 2011
The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteinsA K Elshorbagy, M Valdivia-Garcia, I M Graham, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic strokeD L Harmon, R M Doyle, R Meleady, et al.
The British Journal of Ophthalmology|January 3, 2001
Thermolabile MTHFR genotype and retinal vascular occlusive diseaseM Cahill, M Karabatzaki, C Donoghue, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Biology Letters|January 18, 2023
Directional hydrophone clusters reveal evasive responses of small cetaceans to disturbance during construction at offshore windfarmsI M Graham, D Gillespie, K C Gkikopoulou, et al.
Circulation|May 31, 2001
Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action ProjectL El-Khairy, P M Ueland, H Refsum, et al.
Scandinavian Journal of Social Medicine|January 1, 1986
The relation of social class to risk factors, rehabilitation, compliance and mortality in survivors of acute coronary heart diseaseR M Conroy, S Cahill, R Mulcahy, et al.
Clinical and Experimental Dermatology|June 16, 2010
Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control studyA-M Tobin, R Hughes, E B Hand, et al.
European Heart Journal|August 24, 1999
Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC GroupP Verhoef, R Meleady, L E Daly, et al.
Advances in Therapy|August 4, 2009
Dyslipidemia therapy update: the importance of full lipid profile assessmentI B A Menown, G Murtagh, V Maher, et al.
Circulation|August 10, 2000
Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromesP J Stubbs, M K Al-Obaidi, R M Conroy, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 10, 2011
The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteinsA K Elshorbagy, M Valdivia-Garcia, I M Graham, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 1999
Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic strokeD L Harmon, R M Doyle, R Meleady, et al.
The British Journal of Ophthalmology|January 3, 2001
Thermolabile MTHFR genotype and retinal vascular occlusive diseaseM Cahill, M Karabatzaki, C Donoghue, et al.
Pageof 5